Cargando…
Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors
Epithelial ovarian cancers (EOCs) are a heterogeneous collection of malignancies, each with their own developmental origin, clinical behavior and molecular profile. With less than 5% of EOC cases, mucinous ovarian carcinoma is a rare form with a poor prognosis and a 5-year survival of 11% for advanc...
Autores principales: | Dolivet, Enora, Gaichies, Léopold, Jeanne, Corinne, Bazille, Céline, Briand, Mélanie, Vernon, Mégane, Giffard, Florence, Leprêtre, Frédéric, Poulain, Laurent, Denoyelle, Christophe, Vigneron, Nicolas, Fauvet, Raffaèle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649586/ https://www.ncbi.nlm.nih.gov/pubmed/37958997 http://dx.doi.org/10.3390/ijms242116016 |
Ejemplares similares
-
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma
por: Thorel, Lucie, et al.
Publicado: (2023) -
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy
por: Vigneron, Nicolas, et al.
Publicado: (2016) -
The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels
por: Wambecke, Anaïs, et al.
Publicado: (2021) -
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-X(L) and EGFR leading to BIM activation
por: Denoyelle, C, et al.
Publicado: (2014) -
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
por: Aide, Nicolas, et al.
Publicado: (2021)